Mesa Laboratories, Inc [MLAB] stock is trading at $80.51, down -0.81%. An important factor to consider is whether the stock is rising or falling in short-term value. The MLAB shares have gain 13.84% over the last week, with a monthly amount glided 3.34%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Mesa Laboratories, Inc [NASDAQ: MLAB] stock has seen the most recent analyst activity on August 07, 2025, when Wells Fargo upgraded its rating to a Equal Weight but kept the price target unchanged to $67 for it. Previously, Wells Fargo started tracking the stock with Underweight rating on August 28, 2024, and set its price target to $120. On January 04, 2024, upgrade upgraded it’s rating to Outperform and revised its price target to $125 on the stock. Evercore ISI downgraded its rating to a In-line but stick to its price target of $300 on January 04, 2021. KeyBanc Capital Markets initiated its recommendation with a Sector Weight and recommended $287 as its price target on November 10, 2020. JP Morgan started tracking with a Neutral rating for this stock on October 02, 2020, and assigned it a price target of $260. In a note dated December 04, 2019, Jefferies initiated an Buy rating.
Mesa Laboratories, Inc [MLAB] stock has fluctuated between $55.45 and $155.12 over the past year. Currently, Wall Street analysts expect the stock to reach $120 within the next 12 months. Mesa Laboratories, Inc [NASDAQ: MLAB] shares were valued at $80.51 at the most recent close of the market. An investor can expect a potential return of 49.05% based on the average MLAB price forecast.
Analyzing the MLAB fundamentals
Mesa Laboratories, Inc [NASDAQ:MLAB] reported sales of 245.25M for the trailing twelve months, which represents a growth of 5.02%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is -0.0%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.0 and Total Capital is 0.05. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.07.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 79.36 points at the first support level, and at 78.20 for the second support level. However, for the 1st resistance point, the stock is sitting at 82.27, and for the 2nd resistance point, it is at 84.02.
Ratios To Look Out For
For context, Mesa Laboratories, Inc’s Current Ratio is 2.02. On the other hand, the Quick Ratio is 1.44, and the Cash Ratio is 0.14. Considering the valuation of this stock, the price to sales ratio is 1.81, the price to book ratio is 2.49.
Transactions by insiders
Recent insider trading involved Owens Gary M, President and CEO, that happened on Jun 16 ’25 when 1939.0 shares were sold. SVP Operations, Archbold Brian David completed a deal on Jun 16 ’25 to sell 472.0 shares. Meanwhile, CFO Sakys John sold 642.0 shares on Jun 16 ’25.
